Lahey Hospital & Medical Center

NRC Health Unveils Winners of 2022 Annual Awards Programs

Retrieved on: 
Tuesday, August 16, 2022
NRC, Hospital, Clinical Excellence Awards, Industry, GLOBE, National Research Corporation, Mercy Health, California Hospital Medical Center, Hospital of the University of Pennsylvania, University of Utah Hospital, The Christ Hospital, Morristown Medical Center, Health, Nursing, NPS, Patient, Patient experience, Christ Hospital, Lahey Hospital & Medical Center, Trust, Mayo Clinic Hospital (Rochester), NASDAQ, Â, Organization, Lehigh Valley Health Network, Physician, Community hospital, University, Time, Monterey Peninsula, Pharmaceutical industry, Medicine, Health insurance, Pennsylvania Hospital

LINCOLN, Neb., Aug. 16, 2022 (GLOBE NEWSWIRE) -- NRC Health, the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced the 2022 winners of its annual awards programs, the Consumer Loyalty Awards and the Excellence in Patient Experience Awards, formerly known as the Excellence Awards. NRC Health’s loyalty-based hospital ranking recognizes the top 100 healthcare facilities, including the top 10 Best-In-Class winners, that are working to cultivate and maintain long-lasting loyalty among their patient populations. This year’s Excellence in Patient Experience honorees have been recognized for their efforts to consistently deliver outstanding patient experiences across the care continuum.

Key Points: 
  • LINCOLN, Neb., Aug. 16, 2022 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced the 2022 winners of its annual awards programs, the Consumer Loyalty Awards and the Excellence in Patient Experience Awards , formerly known as the Excellence Awards.
  • Winners of the NRC Health 2022 Excellence in Patient Experience Awards accomplished just that.
  • This years winners include Hawaii Pacific Health, Lehigh Valley Health Network, Mercy Health, and Northwest Community Healthcare as well as repeat winners from last year, Wabash General Hospital, Community Hospital of the Monterey Peninsula, Scottish Rite for Children and Tyron Medical Partners.
  • To see if your local hospital is a 2022 honoree, see the full lists of winning organizations for both the 2022 Consumer Loyalty Awards and the 2022 Excellence in Patient Experience Awards .

Athos Therapeutics Announces Research Collaboration to Advance Precision Medicine in Inflammatory Bowel Disease

Retrieved on: 
Monday, July 11, 2022
Biology, Inflammatory bowel disease, FDA, CEO, Lahey Hospital & Medical Center, Therapy, Precision medicine, Inflammatory Bowel Diseases, Disease, IBD, Enzalutamide, Doctor of Philosophy, CMO, CD, Sex, Division, Company, Crohn's disease, FACS, Ulcerative colitis, MS, Intelligence, Multimedia, Kite Pharma, Degenerative disease, Mission, Cancer, Autoimmune disease, Patient, Research, LOS, UC, Medical Center, MBA, Medical imaging, Pharmaceutical industry, Gastroenterology, MD

 LOS ANGELES, July 11, 2022 /PRNewswire/ -- Athos Therapeutics, Inc. ("Athos"), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced today a comprehensive Master Research Agreement for a collaborative project on Inflammatory Bowel Disease (IBD) with Lahey Hospital & Medical Center ("Lahey"). This collaboration will advance systems biology and computational analyses in the field of Inflammatory Bowel Diseases (IBD).

Key Points: 
  • Athos to perform molecular analysis of biopsies from de-identified Inflammatory Bowel Disease patient samples from Lahey Hospital & Medical Center based in Burlington, Massachusetts.
  • LOS ANGELES, July 11, 2022 /PRNewswire/ -- Athos Therapeutics, Inc. ("Athos"), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced today a comprehensive Master Research Agreement for a collaborative project on Inflammatory Bowel Disease (IBD) with Lahey Hospital & Medical Center("Lahey").
  • This collaboration will advance systems biology and computational analyses in the field of Inflammatory Bowel Diseases (IBD).
  • "We are very excited about our research initiatives with Athos Therapeutics," said Randall Pellish, MD, Director, Lahey Inflammatory Bowel Disease Center, Division of Gastroenterology, Lahey Hospital and Medical Center.

Celebrated Plastic Surgeon, Dr. Roger L. Simpson, Transitions Out of Leadership Roles After 33 Years

Retrieved on: 
Friday, July 8, 2022
Residency, Nassau University Medical Center, Surgeon, Assistant, Patient, Communication, Lahey Hospital & Medical Center, Evans-Haynes Burn Center, Plastic surgery, Burns, Wound, Student, Integration, Plastic and Reconstructive Surgery, Plastic, Burn, GLOBE, Hand surgery, Stony Brook University, Association, Hand, Partnership, Low-residency program, Marketing, NUMC, ReSurge International, Medical Center, Pathology, Trauma, Burn center, Leadership, Program, Long Island Plastic Surgical Group, Interim, Hospital, Dentistry, Flushing

While Dr. Simpson will still maintain his association with NUMC, his trusted colleagues will be stepping in to fulfill his leadership roles at the institution.

Key Points: 
  • While Dr. Simpson will still maintain his association with NUMC, his trusted colleagues will be stepping in to fulfill his leadership roles at the institution.
  • Dr. Simpson held the titles of Chief of Plastic and Reconstructive Surgery, Chief of Hand Surgery, and Director of the Burn Center.
  • His roles as both a leader and educator will continue to influence the field of plastic surgery for decades to come.
  • Long Island Plastic Surgical Group is the largest, longest-running private and academic plastic surgery practice in the United States.

Veracyte Announces New Data Reinforcing Percepta Nasal Swab Test’s Clinical Performance and Utility in Lung Cancer Risk Assessment

Retrieved on: 
Monday, May 16, 2022
Science, Biotechnology, Research, Oncology, Health, Medical Devices, Genetics, Clinical Trials, Intervention, Risk, History, Asilomar International Conference on Climate Intervention Technologies, Medicine, Lahey Hospital & Medical Center, Patient, Smoker, Lung cancer, USPSTF, Conference, ATS, Smoking, American Thoracic Society, Pharmaceutical industry

These findings suggest that the test can be reliably used in ever-smokers whose lung nodules were found incidentally, as well as through screening.

Key Points: 
  • These findings suggest that the test can be reliably used in ever-smokers whose lung nodules were found incidentally, as well as through screening.
  • For the study, researchers evaluated data from a subset of 291 current and former smokers with lung nodules who were part of the original clinical validation study for the Percepta Nasal Swab test.
  • The Percepta Nasal Swab tests performance in classifying lung cancer risk has previously been demonstrated, and it is being made available to a limited number of sites as the company develops the clinical utility evidence to support reimbursement.
  • An example of a forward-looking statement includes, among others, that the Percepta Nasal Swab may help patients more accurately, quickly and confidently assess lung cancer risk so that patients may avoid unnecessary invasive procedures.

Rhino Health Platform Powers Hospital-Based Federated Learning Consortium

Retrieved on: 
Thursday, May 5, 2022
Innovation, American College, MGH, Health, Algorithm, Master of Philosophy, Protocol, Superintendent, Federated, Adoption, Massachusetts General Hospital, Informatics, CEO, AI, Genomic and Medical Data, Medical imaging, Patient, National Taiwan University, Seoul National University Hospital, Hospital, Research fellow, Center, American College of Radiology, Medical Center, Assuta Medical Center, FRCP, Associate, Institute, Advanced Medical Research Center, MBA, FRCR, Bias, Ownership, Privacy, Lahey Hospital & Medical Center, GLOBE, Review, Harvard Medical School, Dasa, Medical device, Pharmaceutical industry, Management, Radiology, Doctor of Philosophy, MD

BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Rhino Health , a distributed compute platform leveraging the privacy-preserving federated learning concept, today announced a hospital-based federated learning for medicine consortium, Federated Learning for Medicine (FL4M).

Key Points: 
  • BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Rhino Health , a distributed compute platform leveraging the privacy-preserving federated learning concept, today announced a hospital-based federated learning for medicine consortium, Federated Learning for Medicine (FL4M).
  • Developers are training AI models across a federated network of seven global hospitals - using federated learning powered by Rhino Health, so that the patient data never leaves the original hospital site.
  • "Rhino Health is proud to support medical researchers around the globe," said Ittai Dayan, MD, CEO and Co-Founder of Rhino Health.
  • Grounded in federated learning, Rhino Health makes it possible to collaborate without ever moving data, transferring ownership, or risking patient privacy.

The Vascular Care Group Welcomes Nationally Recognized Vein Expert Dr. Harold J. Welch

Retrieved on: 
Tuesday, March 15, 2022
Medical Supplies, Health, Medical Devices, Surgery, Other Health, Cardiology, Biotechnology, American Venous Forum (AVF), Society for Vascular Surgery, FACS, Boston, Patient, Hospital, Multimedia, Diagnosis, Â, American College, New England Society of New York, Vascular disease, Tufts University School of Medicine, RVT, Island, Travel, Medicare Physician Group Practice (PGP) Demonstration, Lahey Hospital & Medical Center, U.S. Naval Hospital, Subic Bay, Surgery, American College of Surgeons, Physician, Health, RPVI, Dentistry, Boston (magazine), MD, Cape Cod

View the full release here: https://www.businesswire.com/news/home/20220314005650/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220314005650/en/
    Dr. Harold J. Welch, The Vascular Care Group Hyannis (Photo: Business Wire)
    The Vascular Care Group has established a model that delivers high-level care to patients in the communities where they live, rather than asking the patient to travel to a larger city or healthcare hub, said Dr. Welch.
  • It is very exciting to join a like-minded organization that is a leader in outpatient vascular care in Massachusetts.
  • Prior to joining The Vascular Care Group, Dr. Welch worked as a vascular surgeon at Lahey Clinic in Burlington, Mass.
  • Each care center has united some of the areas leading vascular specialists with a focus on superior patient care.

Stephen L. Demers Joins Memorial Healthcare System as Chief Executive Officer of Memorial Hospital Pembroke

Retrieved on: 
Tuesday, March 8, 2022
YouTube, Master of Business Administration, Bachelor of Science in Nursing, Memorial, Hospital Insurance and Diagnostic Services Act, Twitter, Safety, Memorial Hermann Health System, Hospital, Knowledge, University, Instagram, LinkedIn, Culture, Wound healing, Lahey Hospital & Medical Center, Stroke center, Center, Hyperbaric medicine, E. C. Was Here, Dana–Farber Cancer Institute, Association, Demers, University of South Florida College of Medicine, The Long Beach, Business administration, Brigham and Women's Hospital, Orthopedic surgery, American College, Medical Center, Medicine, Northeastern University, Endocrinology, Facebook

PEMBROKE PINES, Fla., March 8, 2022 /PRNewswire-PRWeb/ --Stephen L. Demers has been named Chief Executive Officer of Memorial Hospital Pembroke , one of six acute-care facilities of Memorial Healthcare System, a public, nonprofit hospital system nationally recognized for providing outstanding patient and family-centered care.

Key Points: 
  • PEMBROKE PINES, Fla., March 8, 2022 /PRNewswire-PRWeb/ --Stephen L. Demers has been named Chief Executive Officer of Memorial Hospital Pembroke , one of six acute-care facilities of Memorial Healthcare System, a public, nonprofit hospital system nationally recognized for providing outstanding patient and family-centered care.
  • This is what makes Memorial Hospital Pembroke, and all of the Memorial Healthcare System, special."
  • Memorial Hospital Pembroke in Pembroke Pines, Fla., is part of Memorial Healthcare System, one of the largest public healthcare systems in the nation.
  • Memorial Hospital Pembroke is highly regarded for its patient and family-centered approach that prioritizes multi-disciplinary collaboration, innovation, and transparency.

MNA Nurses Call Brigham and Women's Hospital's Lax Visitor Policy Unsafe During Omicron COVID Surge; Nurses Worry Hospital is Super Spreader

Retrieved on: 
Tuesday, January 11, 2022
Nursing, Patient, BWH, Policy, Tufts University, Boston Medical Center, Legislature, COVID-19, St. Elizabeth Medical Center, Safety, Workplace, Medical Center, Lahey Hospital & Medical Center, Health, PPE, Time, N95 respirator, Caregiver, Brigham and Women's Hospital, Skype, Association, Education, Hospital, Multimedia, Risk, Commonwealth, Infection, Tufts Medical Center, Friends, FaceTime, Omicron, COVID, Medicine, Brigham, N95

With so many caregivers out with COVID, we would hope hospital executives would step up their efforts to protect us."

Key Points: 
  • With so many caregivers out with COVID, we would hope hospital executives would step up their efforts to protect us."
  • Brigham nurses have been urging the hospital to improve its response to the current COVID surge, but management is not listening.
  • When nurses look at the lax visitor policy, PPE issues and lack of booster and testing availability, they see the Brigham as practically an ongoing super spreader event.
  • Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts.

Wysa, the Leading AI-Powered Mental Health Platform Welcomes New Senior Executive Members

Retrieved on: 
Wednesday, October 13, 2021
Government, Lahey Hospital & Medical Center, National Health Service (England), Geography, Ministry of Health (Saudi Arabia), Industry, Solution, Time, Lead author, Growth, Cincinnati Children's Hospital Medical Center, Depression, CBT, Population, European Institute of Innovation and Technology, Meditation, Insurance, AI, Mindfulness, L'Oréal, Technology, Multimedia, National Health Service, Patient, HEDIS, EAP, Chad, NHS, Human, Mental health, University, Anxiety, Consultant, Entrepreneurship, Associate, Lyra, Medical assistant, Ministry, Pharmaceutical industry, Medicine

Zereana will lead the roll out and management of Wysa's US-based therapy network in support of Wysa's AI + expert human model.

Key Points: 
  • Zereana will lead the roll out and management of Wysa's US-based therapy network in support of Wysa's AI + expert human model.
  • "As a society, we must reimagine the way we think about mental health care.
  • Wysa is a global leader in AI-driven mental health support, available both to individuals and through employer benefits programs.
  • For employers, Wysa offers a workplace solution that caters to the full spectrum of mental health needs.

Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment

Retrieved on: 
Monday, October 11, 2021
Oncology, Medical Supplies, Health, Medical Devices, Clinical Trials, Research, Science, Twitter, Lung, Forward-looking statement, CT, Patient, Large-cell lung carcinoma, Health, Risk, Idiopathic pulmonary fibrosis, GSC, Kidney, American College of Chest Physicians, PPV, NanoString Technologies, Lung cancer, Breast cancer, Physician, Form 10-Q, Prostate cancer, Investor, NSCLC, Diagnosis, Cancer, Population, Annual report, SEC, NPV, Smoker, Medical Center, Lahey Hospital & Medical Center, Medical college, Bladder cancer, AnMed Health Medical Center, American College, Technology, Medical College of Wisconsin, Thyroid cancer, Annual general meeting, Medical imaging, Lung Cancer, Veracyte, LUNG CANCER, VERACYTE

(Nasdaq: VCYT) today announced that new expanded clinical validation data reinforce the ability of the companys noninvasive Percepta Nasal Swab test to help physicians more accurately assess lung cancer risk in patients with lung nodules.

Key Points: 
  • (Nasdaq: VCYT) today announced that new expanded clinical validation data reinforce the ability of the companys noninvasive Percepta Nasal Swab test to help physicians more accurately assess lung cancer risk in patients with lung nodules.
  • Veracyte also announced it has begun making the Percepta Nasal Swab test available to a limited number of clinical sites as it builds the clinical utility data to support reimbursement.
  • Our findings reinforce the Percepta Nasal Swab tests ability to more accurately identify patients as low, moderate or high risk for lung cancer so that physicians can make more confident decisions about next steps for their patients.
  • The Percepta Nasal Swab tests robust performance in classifying lung cancer risk was previously demonstrated in a blinded, independent validation set of 249 patients from multiple cohorts comprising prospectively collected nasal samples.